Anchor Capital Advisors LLC Trims Stock Holdings in Corteva, Inc. $CTVA

Anchor Capital Advisors LLC decreased its position in Corteva, Inc. (NYSE:CTVAFree Report) by 4.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 637,237 shares of the company’s stock after selling 26,567 shares during the quarter. Anchor Capital Advisors LLC owned approximately 0.09% of Corteva worth $42,714,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of CTVA. Brighton Jones LLC increased its position in Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after buying an additional 11,760 shares in the last quarter. Woodline Partners LP grew its stake in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after acquiring an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Corteva by 62.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after acquiring an additional 980 shares in the last quarter. Cresset Asset Management LLC raised its position in shares of Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares during the last quarter. Finally, Jump Financial LLC bought a new position in Corteva in the 2nd quarter worth about $1,464,000. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Down 0.2%

CTVA opened at $77.50 on Wednesday. The stock has a market cap of $51.83 billion, a price-to-earnings ratio of 45.59, a price-to-earnings-growth ratio of 2.38 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The firm’s fifty day moving average is $81.32 and its 200 day moving average is $74.68. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63.

Corteva (NYSE:CTVAGet Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same quarter in the prior year, the business posted $1.13 EPS. Corteva’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is 42.35%.

Analysts Set New Price Targets

CTVA has been the subject of several recent analyst reports. Citigroup lifted their target price on shares of Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Wells Fargo & Company raised their price target on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. The Goldman Sachs Group upped their price target on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, April 14th. Wall Street Zen cut shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Finally, Berenberg Bank raised their target price on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research report on Thursday, March 26th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $88.67.

Get Our Latest Analysis on CTVA

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.